Monopar Therapeutics Shares Are Trading Lower After Gaining Thursday. The Stock Was Volatile Yesterday After the Company Entered Into an Agreement With Alexion, AstraZeneca Rare Disease, for an Exclusive Worldwide License to ALXN-1840 for Wilson Disease.
Monopar Therapeutics Shares Are Trading Lower After Gaining Thursday. The Stock Was Volatile Yesterday After the Company Entered Into an Agreement With Alexion, AstraZeneca Rare Disease, for an Exclusive Worldwide License to ALXN-1840 for Wilson Disease.
monopar therapeutics股價週四上漲後下跌。昨天該股票波動較大，因公司與Alexion、阿斯利康罕見疾病達成協議，獨家獲得ALXN-1840在威爾遜氏病方面的全球專利許可。
Monopar Therapeutics Shares Are Trading Lower After Gaining Thursday. The Stock Was Volatile Yesterday After the Company Entered Into an Agreement With Alexion, AstraZeneca Rare Disease, for an Exclusive Worldwide License to ALXN-1840 for Wilson Disease.
monopar therapeutics股價週四上漲後下跌。昨天該股票波動較大，因公司與Alexion、阿斯利康罕見疾病達成協議，獨家獲得ALXN-1840在威爾遜氏病方面的全球專利許可。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間